Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have received an average rating of “Buy” from the twelve research firms that are currently covering the stock ...

Revolution Medicines Inc (RVMD) stock soared to a 52-week high, reaching $51.01, marking a significant milestone for the ...

Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...

At close: April 17 at 4:00:01 PM EDT ...

In a recent transaction, Jeff Cislini, the General Counsel of Revolution Medicines, Inc. (NASDAQ:RVMD), sold a total of 1,500 ...

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally. The company’s ...